ArticleFrontiers in immunology2022

Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments.

Tengda Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.